Pediatric antifungal utilization: new drugs, new trends (Q46260776)

20 December 2017

title

Pediatric antifungal utilization: new drugs, new trends (English)

1 reference

20 December 2017

4

Thomas J Walsh

1 reference

20 December 2017

Susan E. Coffin

2

object named as

Susan E Coffin

1 reference

20 December 2017

Theoklis E. Zaoutis

5

object named as

Theoklis E Zaoutis

1 reference

20 December 2017

author name string

Priya A Prasad

1

1 reference

20 December 2017

Kateri H Leckerman

3

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

Pediatric Infectious Disease Journal

published in

1 reference

20 December 2017

volume

27

1 reference

20 December 2017

issue

12

1 reference

20 December 2017

page(s)

1083-1088

1 reference

20 December 2017

Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services

cites work

1 reference

12 December 2020

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months

1 reference

12 December 2020

Outcomes attributable to neonatal candidiasis

1 reference

12 December 2020

Shifting place of death among children with complex chronic conditions in the United States, 1989-2003.

1 reference

12 December 2020

Excess costs of hospital care associated with neonatal candidemia

1 reference

12 December 2020

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

1 reference

12 December 2020

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

1 reference

12 December 2020

Pediatric aspergillosis: disease and treatment differences in children

1 reference

12 December 2020

Antifungal therapy in children with invasive fungal infections: a systematic review.

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

New antifungal agents under development in children and neonates

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents

1 reference

12 December 2020

A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

1 reference

12 December 2020

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

1 reference

12 December 2020

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

1 reference

12 December 2020

Risk factors for mortality in children with candidemia

1 reference

12 December 2020

New agents for invasive mycoses in children

1 reference

12 December 2020

Fluconazole prophylaxis against fungal colonization and infection in preterm infants

1 reference

12 December 2020

Mycoses in pediatric patients

1 reference

12 December 2020

Antifungal treatment in pediatric patients

1 reference

12 December 2020

Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.

1 reference

12 December 2020

10.1097/INF.0B013E31817EEEE5

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017